Capex / revenue moved 224 bp lower
Capex / revenue changed -224 basis points from the comparable as-filed period.
6.22%→3.98%2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →EMN financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capital expenditure decreased 30.7%
Capital expenditure changed -30.7% from the comparable as-filed period.
$137.0M→$95.0M2 prior comparisons
Noncurrent long-term debt decreased 6.9%
Noncurrent long-term debt changed -6.9% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$4.8B→$4.5B4 prior comparisons
Operating cash-flow margin moved 610 bp lower
Operating cash-flow margin changed -610 basis points from the comparable as-filed period.
18.26%→12.16%2 prior comparisons
Inventory increased 12.9%
Inventory changed +12.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$1.9B→$2.2B4 prior comparisons
Free-cash-flow margin moved 386 bp lower
Free-cash-flow margin changed -386 basis points from the comparable as-filed period.
12.03%→8.18%2 prior comparisons
Stock-based compensation increased 23.1%
Stock-based compensation changed +23.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$13.0M→$16.0M2 prior comparisons
Operating cash flow / net income decreased 86.5%
Operating cash flow / net income changed -86.5% from the comparable as-filed period.
8.55→1.152 prior comparisons
Receivables / revenue moved 216 bp higher
Receivables / revenue changed +216 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
42.37%→44.53%2 prior comparisons
Revenue increased 8.3%
Revenue changed +8.3% from the comparable as-filed period.
$2.2B→$2.4B2 prior comparisons
Current assets increased 15.3%
Current assets changed +15.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$3.8B→$4.4B4 prior comparisons
Gross profit increased 22.9%
Gross profit changed +22.9% from the comparable as-filed period.
$433.0M→$532.0M2 prior comparisons
Shares outstanding increased 0.3%
Shares outstanding changed +0.3% from the comparable as-filed period. The change ranks at the 0th percentile of 8 prior comparable changes. This reverses 8 consecutive comparable moves in the opposite direction.
114,069,800→114,380,4568 prior comparisons
Cost of revenue increased 4.7%
Cost of revenue changed +4.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$1.8B→$1.9B2 prior comparisons
SBC / revenue moved 8 bp higher
SBC / revenue changed +8 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
0.59%→0.67%2 prior comparisons
Total assets increased 3.3%
Total assets changed +3.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$15.0B→$15.5B4 prior comparisons
Current ratio decreased 10.4%
Current ratio changed -10.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
1.76→1.574 prior comparisons
Working capital decreased 2.3%
Working capital changed -2.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$1.6B→$1.6B4 prior comparisons
Working capital / assets moved 59 bp lower
Working capital / assets changed -59 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
10.89%→10.30%4 prior comparisons
R&D / revenue moved 22 bp lower
R&D / revenue changed -22 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
2.86%→2.64%2 prior comparisons
Selling, general & administrative increased 6.9%
Selling, general & administrative changed +6.9% from the comparable as-filed period.
$160.0M→$171.0M2 prior comparisons
Research & development unchangedd 0.0%
Research & development changed +0.0% from the comparable as-filed period.
$63.0M→$63.0M2 prior comparisons
Capital expenditure decreased 33.3%
Capital expenditure changed -33.3% from the comparable as-filed period.
$150.0M→$100.0M3 prior comparisons
Stock-based compensation increased 850.0%
Stock-based compensation changed +850.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$2.0M→$19.0M2 prior comparisons
Noncurrent long-term debt decreased 6.9%
Noncurrent long-term debt changed -6.9% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$4.8B→$4.5B4 prior comparisons
Revenue increased 9.9%
Revenue changed +9.9% from the comparable as-filed period.
$2.3B→$2.5B2 prior comparisons
Working capital decreased 13.4%
Working capital changed -13.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$1.6B→$1.4B4 prior comparisons
Cost of revenue increased 9.7%
Cost of revenue changed +9.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$1.8B→$2.0B2 prior comparisons
Operating cash flow / net income decreased 26.5%
Operating cash flow / net income changed -26.5% from the comparable as-filed period.
1.66→1.222 prior comparisons
SBC / revenue moved 67 bp higher
SBC / revenue changed +67 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
0.09%→0.76%2 prior comparisons
Gross margin moved 16 bp higher
Gross margin changed +16 basis points from the comparable as-filed period.
22.13%→22.28%2 prior comparisons
Selling, general & administrative increased 17.8%
Selling, general & administrative changed +17.8% from the comparable as-filed period.
$157.0M→$185.0M2 prior comparisons
Working capital / assets moved 156 bp lower
Working capital / assets changed -156 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
10.74%→9.17%4 prior comparisons
Operating cash flow decreased 3.9%
Operating cash flow changed -3.9% from the comparable as-filed period.
$233.0M→$224.0M3 prior comparisons
Operating cash-flow margin moved 127 bp lower
Operating cash-flow margin changed -127 basis points from the comparable as-filed period.
10.19%→8.91%2 prior comparisons
Shares outstanding decreased 0.4%
Shares outstanding changed -0.4% from the comparable as-filed period. The change ranks at the 0th percentile of 8 prior comparable changes.
114,832,412→114,377,4218 prior comparisons
Research & development decreased 3.0%
Research & development changed -3.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$67.0M→$65.0M2 prior comparisons
Current ratio decreased 11.1%
Current ratio changed -11.1% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
1.68→1.54 prior comparisons
Current assets increased 5.8%
Current assets changed +5.8% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$4.0B→$4.3B4 prior comparisons
Gross profit increased 10.7%
Gross profit changed +10.7% from the comparable as-filed period.
$506.0M→$560.0M2 prior comparisons
Free-cash-flow margin moved 131 bp higher
Free-cash-flow margin changed +131 basis points from the comparable as-filed period.
3.63%→4.93%2 prior comparisons
Inventory decreased 2.3%
Inventory changed -2.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$2.2B→$2.1B4 prior comparisons
Receivables / revenue moved 45 bp higher
Receivables / revenue changed +45 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
43.20%→43.65%2 prior comparisons
Total assets increased 1.3%
Total assets changed +1.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$15.2B→$15.4B4 prior comparisons
R&D / revenue moved 34 bp lower
R&D / revenue changed -34 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
2.93%→2.59%2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.